ArticleDiabetes care2013

Response to comment on: Butler et al. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe? Diabetes Care 2013;36:2118-2125.

Edwin A M GalePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.